| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.17 | 0.4 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |